• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL Back to Search Results
Catalog Number BXA085901J
Device Problem Patient Device Interaction Problem (4001)
Patient Problem Unspecified Infection (1930)
Event Date 11/23/2022
Event Type  Injury  
Manufacturer Narrative
Cbas® heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.As it is unknown which device(s) may have contributed to the reported graft related infection and reintervention, two additional gore® viabahn® vbx balloon expandable endoprosthesis(vbx) devices have been included in this report: (b)(4) (udi/(b)(4) and (b)(4) (udi/(b)(4).W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
On (b)(6) 2022, this patient underwent endovascular treatment of an aortoiliac occlusive disease/leriche syndrome using gore® viabahn® vbx balloon expandable endoprostheses (vbx).Three vbx devices were implanted, and the procedure was completed without any issue.On an unknown date in (b)(6) 2022, a graft infection was suspected.Reportedly, the patient had fever and back pain postoperatively, blood culture was performed twice and staphylococci was detected on both times.Furthermore, an abscess near the left iliopsoas muscle was observed on the ct imaging, and there was a suspicion of hydronephrosis due to compression of the ureter between the iliopsoas muscle and the abscess.On (b)(6) 2022, antimicrobial therapy was initiated and the fever improved.On (b)(6) 2022 ct guided percutaneous drainage was performed for the iliopsoas abscess.The patient tolerated the procedure.
 
Manufacturer Narrative
Updated h10/11 investigation findings and investigation conclusions.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS
Type of Device
ILIAC COVERED STENT, ARTERIAL
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
marcos ayala
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key15996647
MDR Text Key305617528
Report Number2017233-2022-03581
Device Sequence Number1
Product Code PRL
Combination Product (y/n)Y
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 02/02/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/16/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Catalogue NumberBXA085901J
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received11/24/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/29/2022
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Age58 YR
Patient SexMale
-
-